COVID-19 vaccine race: Spotlight on Pfizer, Moderna as trial data to be released soon

- Moderna's COVID-19 vaccine has produced a strong immune response in older adults with no serious adverse effects during phase I trial, shows study
- Pfizer’s coronavirus vaccine could be distributed before the end of the year if found to be safe and effective, CEO said